Founded in 1950, Harbin Pharmaceutical Group Co., Ltd. initially focused on the production of intramuscular and intravenous water injections, and has now developed into a comprehensive pharmaceutical enterprise focusing on OTC products, prescription drugs and health foods, as well as pharmaceutical raw materials and preparations
Founded in 1950, Sanjing Pharmaceutical Co., Ltd. was the first enterprise in Heilongjiang Province to specialize in the production of water injections and the earliest domestic enterprises to introduce foreign water injection production equipment, and is one of the earliest pharmaceutical companies to pass the national GMP certification. With a total area of 1.1 million square meters and a total of nearly 6,000 employees, the company is a comprehensive pharmaceutical enterprise focusing on OTC products, prescription drugs and health foods, and paying equal attention to pharmaceutical raw materials and preparations.
At present, Sanjing Pharmaceutical has 15 subsidiaries, including 8 industrial subsidiaries, 5 commercial subsidiaries, and 2 subsidiaries in other related industries. Up to now, the company has 13 dosage forms of oral liquid, oral solution, small-volume injection (non-terminal sterilization), lyophilized powder injection, tablet, powder injection, capsule, granule, mixture, syrup, lotion, tea, powder, and sterile APIs (fosfomycin sodium, Yansuccining) and APIs (lasidipine, roxatidine hydrochloride acetate) have passed the 2010 GMP certification. Among them, the annual production capacity of oral liquid dosage form products reaches 1.6 billion. The company's leading products include calcium gluconate oral solution, zinc gluconate oral solution, Shuanghuanglian oral liquid, selepine tablets, etc. In recent years, through the research and development of new products for drugs and health products, we have continuously improved the product line and enriched the product lineup.
With more than 60 years of pharmaceutical experience, advanced technology and equipment, first-class management methods, and perfect scientific research and development system, the "Sanjing" brand enjoys a high reputation at home and abroad. Sanjing has always regarded products and services as the core competitiveness, and at the same time attaches great importance to product research and development, in 2004 built a relatively large-scale research and development center, has become Heilongjiang Province Pharmaceutical Preparation Engineering Technology Research Center, Heilongjiang Province Key Laboratory of Western Medicine Preparations, to undertake the "Eleventh Five-Year Plan" "major new drug creation" science and technology major project - "new oral sustained release preparation and process technology platform" project and "Twelfth Five-Year" "major new drug creation" science and technology major project - Research and development of anti-Alzheimer's disease drug rivastigmine tartrate and its capsules". In 2008, the company became the "first batch of innovative enterprises in the country", and in 2012, it was selected as a key high-tech enterprise in the National Torch Program. The company has also won the national advanced enterprise of quality management, the national contract-abiding and trustworthy enterprise, the national outstanding enterprise of the pharmaceutical system, the national "May 1st Labor Award" advanced collective, the "National Enterprise Culture Outstanding Achievement Award", "the national pharmaceutical industry drug quality integrity construction demonstration enterprise", "21315 international quality credit AAA level", "China Excellent Integrity Enterprise", "China's top 100 industrial enterprises in China's chemical and pharmaceutical industry with comprehensive strength" enterprise, Heilongjiang Province "Science and Technology Innovation Outstanding Enterprise Award" and other honorary titles.
